ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
3.670
+0.070 (1.94%)
Nov 20, 2024, 4:00 PM EST - Market closed
ProQR Therapeutics Employees
ProQR Therapeutics had 157 employees as of December 31, 2023. The number of employees increased by 26 or 20.28% compared to the previous year.
Employees
157
Change (1Y)
26
Growth (1Y)
20.28%
Revenue / Employee
$130,947
Profits / Employee
-$170,511
Market Cap
378.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Valneva SE | 676 |
Revance Therapeutics | 597 |
AirSculpt Technologies | 381 |
Alector | 244 |
KalVista Pharmaceuticals | 150 |
PRQR News
- 26 days ago - ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 4 weeks ago - ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 4 weeks ago - ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares - GlobeNewsWire
- 6 weeks ago - ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 2 months ago - ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 6 months ago - ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript) - Seeking Alpha
- 7 months ago - ProQR Announces First Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 7 months ago - ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 - GlobeNewsWire